Daré Bioscience, Inc. reported earnings results for the third quarter ended September 30, 2023. For the third quarter, the company reported revenue was USD 1 million. Net loss was USD 8.3 million compared to USD 7.02 million a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.349 USD | +23.80% | +14.36% | +10.03% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.03% | 28.35M | |
+1.43% | 42.86B | |
+12.37% | 42.74B | |
+44.81% | 41.36B | |
-8.83% | 27.68B | |
+7.33% | 25.15B | |
-23.24% | 18.63B | |
+29.90% | 12.37B | |
-2.85% | 11.92B | |
+7.19% | 11.21B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Daré Bioscience, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2023